These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29790383)

  • 21. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.
    Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B
    Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
    Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
    Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncological and Functional Outcomes of Whole-Gland HIFU as the Primary Treatment for Localized Prostate Cancer: A Systematic Review.
    Guang ZLP; Kristensen G; Røder A; Brasso K
    Clin Genitourin Cancer; 2024 Aug; 22(4):102101. PubMed ID: 38811288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External validation of biochemical recurrence definition to predict oncologic outcomes following focal therapy for localized prostate cancer using high intensity focused ultrasound.
    Mattlet A; Limani K; Alexandre P; Hawaux E; Abou Zahr R; Aoun F; Diamand R
    Prostate; 2023 Dec; 83(16):1564-1571. PubMed ID: 37574824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
    Thüroff S; Chaussy C
    J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer.
    Kanthabalan A; Peters M; Van Vulpen M; McCartan N; Hindley RG; Emara A; Moore CM; Arya M; Emberton M; Ahmed HU
    BJU Int; 2017 Aug; 120(2):246-256. PubMed ID: 28258616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Available evidence on HIFU for focal treatment of prostate cancer: a systematic review.
    Bakavicius A; Marra G; Macek P; Robertson C; Abreu AL; George AK; Malavaud B; Coloby P; Rischmann P; Moschini M; Rastinehad AR; Sidana A; Stabile A; Tourinho-Barbosa R; de la Rosette J; Ahmed H; Polascik T; Cathelineau X; Sanchez-Salas R
    Int Braz J Urol; 2022; 48(2):263-274. PubMed ID: 34003610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Focal HIFU vs robot-assisted total prostatectomy: Functionnal and oncologic outcomes at one year].
    Arnouil N; Gelet A; Matillon X; Rouviere O; Colombel M; Ruffion A; Mège-Lechevallier F; Subtil F; Badet L; Crouzet S
    Prog Urol; 2018 Oct; 28(12):603-610. PubMed ID: 30243461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Exploratory Study of Dose Escalation
    Huber PM; Afzal N; Arya M; Boxler S; Dudderidge T; Emberton M; Guillaumier S; Hindley RG; Hosking-Jervis F; Leemann L; Lewi H; McCartan N; Moore CM; Nigam R; Odgen C; Persad R; Thalmann GN; Virdi J; Winkler M; Ahmed HU
    J Endourol; 2020 Jun; 34(6):641-646. PubMed ID: 32253928
    [No Abstract]   [Full Text] [Related]  

  • 30. Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy.
    Uddin Ahmed H; Cathcart P; Chalasani V; Williams A; McCartan N; Freeman A; Kirkham A; Allen C; Chin J; Emberton M
    Cancer; 2012 Jun; 118(12):3071-8. PubMed ID: 22071795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
    Pfeiffer D; Berger J; Gross AJ
    BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal Therapy for Prostate Cancer with In-Bore MR-guided Focused Ultrasound: Two-Year Follow-up of a Phase I Trial-Complications and Functional Outcomes.
    Tay KJ; Cheng CWS; Lau WKO; Khoo J; Thng CH; Kwek JW
    Radiology; 2017 Nov; 285(2):620-628. PubMed ID: 28654336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focal high-intensity focused ultrasound therapy for localized prostate cancer: An interim analysis of the multinational FASST study.
    Ladjevardi S; Ebner A; Femic A; Huebner NA; Shariat SF; Kraler S; Kubik-Huch RA; Ahlman RC; Häggman M; Hefermehl LJ
    Eur J Clin Invest; 2024 Jun; 54(6):e14192. PubMed ID: 38445798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extra-target low-risk prostate cancer: implications for focal high-intensity focused ultrasound of clinically significant prostate cancer.
    Annoot A; Olivier J; Valtille P; Deken V; Leroy X; Puech P; Villers A
    World J Urol; 2019 Feb; 37(2):261-268. PubMed ID: 30116963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-intensity focused ultrasound for prostate cancer: a systematic review.
    Lukka H; Waldron T; Chin J; Mayhew L; Warde P; Winquist E; Rodrigues G; Shayegan B;
    Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):117-27. PubMed ID: 20932728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage high-intensity focused ultrasound for locally recurrent prostate cancer after low-dose-rate brachytherapy: oncological and functional outcomes.
    Hostiou T; Gelet A; Chapelon JY; Rouvière O; Mège-Lechevalier F; Lafon C; Tonoli-Catez H; Badet L; Crouzet S
    BJU Int; 2019 Nov; 124(5):746-757. PubMed ID: 31148367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High intensity focused ultrasound with Focal-One
    Perez-Reggeti JI; Sanchez-Salas R; Sivaraman A; Linares Espinos E; de Gracia-Nieto AE; Barret E; Galiano M; Rozet F; Fregeville A; Renard-Penna R; Cathala N; Mombet A; Prapotnich D; Cathelineau X
    Actas Urol Esp; 2016 Dec; 40(10):608-614. PubMed ID: 27543259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvage high-intensity focused ultrasound for patients with recurrent prostate cancer after brachytherapy.
    Yutkin V; Ahmed HU; Donaldson I; McCartan N; Siddiqui K; Emberton M; Chin JL
    Urology; 2014 Nov; 84(5):1157-62. PubMed ID: 25443920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer.
    Stabile A; Orczyk C; Hosking-Jervis F; Giganti F; Arya M; Hindley RG; Dickinson L; Allen C; Punwani S; Jameson C; Freeman A; McCartan N; Montorsi F; Briganti A; Ahmed HU; Emberton M; Moore CM
    BJU Int; 2019 Sep; 124(3):431-440. PubMed ID: 30753756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HIFU therapy of localized prostate cancer using image-guided robotic HIFU Focal One].
    Govorov AV; Vasilyev AO; Alaverdyan AI; Kolontarev KB; Pushkar DY
    Urologiia; 2023 May; (2):83-89. PubMed ID: 37401710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.